Clinical Trials
16 trialsNCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting
NCT06996249 2026-03-03
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
Recruiting
NCT01385722 2025-12-26
Molecular Analysis of Thoracic Malignancies
Stanford University
Enrolling by invitation
NCT07072143 2025-07-18
PARTNER
Azienda Ospedaliera di Padova
Recruiting
NCT05667948 2025-05-22
Molecular Analysis and Treatment Options of Thymic Malignancies
Shanghai Chest Hospital
Recruiting
NCT06692062 2024-11-18
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Xiangya Hospital of Central South University
Phase NA Recruiting
NCT00591981 2023-06-05
TOGA
University of Wisconsin, Madison
Completed
NCT02688166 2022-10-13
Cardiac MRI Biomarker Testing (GCC 1618)
University of Maryland, Baltimore
Terminated
NCT03023319 2022-06-14
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Augusta University
Phase 1 Completed
NCT00921739 2020-04-02
ESIMRT
Duke University
Phase 1 Completed
NCT01165658 2020-01-02
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies
M.D. Anderson Cancer Center
Phase 1 Terminated
NCT02364076 2019-12-13
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
Phase 2 Unknown
NCT01364727 2019-04-16
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Stanford University
Phase 2 Completed
NCT03078699 2017-03-13
Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment
Third Military Medical University
Phase NA Completed
NCT01135849 2015-11-17
B-Receptor Signaling in Cardiomyopathy
Stanford University
Completed
NCT00369889 2014-06-03
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
Indiana University
Phase 2 Completed